Yahoo Finance Plus 
If you add Doximity (NYSE: DOCS) and DermTech (NASDAQ: DMTK) to a diversified portfolio, they could help you turn $100,000 into $1 million over the next decade. Doximity has truly become a primary platform that medical professionals use.
This super investor is going against the herd. Maybe you should, too.
JPMorgan Chase increased its guidance earlier today and Bank of America's CEO had positive comments about the economy.
Shares of Apple (NASDAQ: AAPL) climbed higher on Monday, adding as much as 4.1%. The catalysts that sent shares higher were several reports that were good news for Apple shareholders. A report over the weekend suggested that the iPhone maker is looking to increase its production outside China, according to The Wall Street Journal.
Catalyst Biosciences Inc (NASDAQ: CBIO) has agreed to sell its portfolio of protease medicines that regulate complement to Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) for $60 million. "This sale is part of the ongoing strategic process that we announced in February to explore alternatives and create value for shareholders. We have significantly reduced our cash burn and continue to work with our advisors to evaluate additional strategic alternatives for Catalyst," said Nassim Usman, CEO o
A new report highlights the layoffs and capital raises Carvana has made to adjust to current business conditions.
Shares of the electric vehicle maker Rivian Automotive (NASDAQ: RIVN) fell this morning, likely because investors were processing news about growing frustration about wait times for customers who've pre-ordered Rivian vehicles. This morning Reuters reported that there's growing frustration among people who have pre-ordered Rivian vehicles -- some orders date back to 2019 -- and are waiting longer to receive their vehicles than people who ordered after them. The report comes just weeks after Rivian said that it would focus some of its production on vehicles with certain colors and wheel accessories in order to maximize production.
Last week, the S&P 500 finished Friday’s session with a rally that gave the index a small gain of 0.15% for the day. It was a good thing, too, since the index flirted with a net-20% loss during the session. That’s bear market territory, the kind of market move that will further spook investors after a springtime of headwinds. Inflation is running at 40-year high levels, Q1 showed a net economic contraction, Russia’s war on Ukraine promises to further damage supplies and prices in the food, cooki
(Bloomberg) -- Dennis Gartman is telling prospective dip buyers to sell any rallies in US stocks during a bear market that he dates to the start of the year, and expects to last for many months.Most Read from BloombergBroadcom in Talks to Acquire Cloud Company VMwareStocks Climb in Risk-On Day While Bonds Decline: Markets WrapBiden Misspeaks on Taiwan, Says US Military Would InterveneWalmart’s Troubles Should Have Everyone on High AlertGoldman’s Solomon Says Subway Shooting of Employee a ‘Sensel
Movie-theater chain AMC Entertainment (NYSE: AMC) is in the process of giving back last-week's gains. Last week, AMC announced it took a near-7% stake in movie-advertising outfit National CineMedia. It's been an unfortunate consequence of AMC's meme-stock status that its shares are highly volatile, which more often than not causes it to briefly shoot higher, only to end up lower than where it began.
Yahoo Finance Live anchors discuss first-quarter earnings for Chinese EV maker XPeng.
Nio investors are worried that if XPeng is continuing to feel the pinch from strict COVID regulations in China, then Nio will, too. Both Nio and XPeng are based in China, and the Chinese government has a strict "zero-COVID" policy that requires companies, production facilities, and even cities to shut down when coronavirus cases are detected. The policy has wreaked havoc on many areas of the Chinese economy and caused massive vehicle production headaches for Nio, XPeng, Tesla, and other companies making vehicles in the country.
These passive income powerhouses, with yields ranging between 5.5% and 12%, can combat historically high inflation and make patient investors richer over time.
Amazon (NASDAQ: AMZN) has had a volatile few years since the pandemic's onset. As economies reopen, sales growth is slowing down but remaining at high levels. Let's look at three reasons investors should buy Amazon stock and one reason to be cautious.
Yahoo Finance Live’s Jared Blikre discusses the boost in stock for JPMorgan Chase.
Seesawing semiconductor stock Nvidia (NASDAQ: NVDA) moved lower ahead of its expected Wednesday-evening earnings report, falling 2.1% through 10:55 a.m. ET on Monday (although it's back in the green now at midday). Two separate analysts lowered their price targets for Nvidia ahead of the report, with UBS cutting the shares to $280 and Bernstein predicting a $225 target price. Both analysts pointed to worries about falling demand for GPUs in the gaming segment as the reason for their cuts, reports TheFly.com, although UBS said demand probably won't "fall off ... quite yet" -- referring to Nvidia's Q1 results.
If a major recession is coming, the financial guru recommends some fast, concrete moves to protect your money.
The Russian ruble has emerged as the best-performing currency in 2022, despite wide-ranging sanctions imposed for its invasion of Ukraine. How did the Russian currency make a dramatic recovery from its record low of 143 rubles to the dollar on March 7? The rally, experts say, is largely artificial, the result of capital controls imposed by Moscow in the wake of Western sanctions.
Shares of Johnson & Johnson (NYSE: JNJ) climbed higher this morning and are trading up 2.2% as of 11 a.m. ET. The healthcare giant received a thumbs-up from an analyst, who sees roughly 14% upside in Johnson & Johnson stock from yesterday's close. Analyst David Risinger from healthcare-focused investment bank SVB Leerink gave Johnson & Johnson stock an outperform rating with a price target of $200 per share, according to TheFly.com.
Yahoo Finance Live anchors discuss China stocks as Didi proceeds to delist from the New York Stock Exchange.
Despite a steep 89% decline from all-time highs, this stock is back on the rise and up 77% from its 52-week low.
Yahoo Finance